05:22 PM EDT, 04/10/2025 (MT Newswires) -- Yann Mazabraud, Executive Vice President, Head of International, on April 08, 2025, sold 17,750 shares in Rhythm Pharmaceuticals ( RYTM ) for $1,082,497. Following the Form 4 filing with the SEC, Mazabraud has control over a total of 22,620 common shares of the company, with 22,620 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1649904/000110465925033820/xslF345X05/tm2512047-1_4seq1.xml